Video
Let's talk antitrust: Discussing recent cases and emerging competition issues
Recent cases and judgments have shone a light on some emerging themes and trends that companies will want to consider as part of their risk management framework.
Remember to subscribe to our Health Law Pulse blog to receive the latest updates on healthcare enforcement and regulations.
Stark and Anti-Kickback, the next frontier: An examination of the new Final Rules and their impact | Speakers: Stacey Murphy, Jeff Wurzburg, Joseph Keillor and Elise LeGros
Legal issues with infectious diseases: The good, the bad and the ugly | Speakers: Yvonne K. Puig, Kevin Mayer and Jackie Karama
View our pharma litigation team’s new 3-minute video series on legal updates relevant to pharmaceutical and medical device industries.
Video
Recent cases and judgments have shone a light on some emerging themes and trends that companies will want to consider as part of their risk management framework.
Publication
After a lacklustre finish to 2022 when compared to the vintage year for M&A that was 2021, dealmakers expected 2023 to see the market continue to cool in most sectors, in response to the economic headwinds of rising inflation (with its corresponding impact on financing costs), declining market valuations, tightening regulatory scrutiny and increasing geopolitical tensions.
Publication
On 18 September 2023, the CMA published its Initial Report (Initial Report) on AI Foundation Models (FM), supplemented in April 2024 with the publication of its “Update Paper” focused on potential antitrust risks associated with FMs and a “Technical Update Report” providing more detail on the development on FMs (collectively the “Reports”). Below, we consider these CMA publications.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023